NCT03437616

Brief Summary

This study investigates the effectiveness of a Finnish Tulppa outpatient rehabilitation program. Tulppa is a group-based secondary prevention program for patients with vascular diseases. The program is developed by the Finnish Heart Association. The intervention is implemented at the local primary health care centers in 12 health districts in Finland. A longitudinal controlled study is used to investigate the effects of the intervention on participants' level of cardiovascular risk factors (e.g. lipids, blood pressure, body mass index), functional capacity (e.g. 6 minute walk test), life style as well as psychosocial factors (e.g. smoking, diet, physical activity, health-related quality of life and depression). The data will be collected at baseline (i.e. before the intervention), and 6 and 12 months after the intervention started. The participants (n = 300) are patients diagnosed with coronary heart disease. The study group (n = 150) is recruited from participants of Tulppa rehabilitation in three health care districts (Pirkanmaa, South Karelia, Päijät-Häme). The control group (n = 150) is recruited from two health care districts (Turku and Hyvinkää) that do not provide Tulppa rehabilitation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
43mo left

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Feb 2018Dec 2029

First Submitted

Initial submission to the registry

January 10, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

February 19, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2020

Completed
9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Expected
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

2.8 years

First QC Date

January 10, 2018

Last Update Submit

July 12, 2024

Conditions

Keywords

RehabilitationCoronary heart diseaseCardiovascular diseasesRisk factorsLife-style changesEfficacy

Outcome Measures

Primary Outcomes (2)

  • Health related quality of life

    Health related quality of life is assessed with the finnish version of RAND-36-Item Health Survey (36-Item Short Form Survey Instrument - SF-36; Aalto, Aro \& Teperi, 1999). The RAND-36 is a generic health-related survey consisting of 36 items with eight sub-scales: 1. general health, 2. bodily pain, 3. physical functioning, 4. role limitations/physical, 5. role limitations/emotional, 6. vitality, 7. mental health, and 8. social functioning. The total score is a sum of the eight subscales and the range is 0 - 100. Higher scores on the scale indicate a better quality of life.

    Changes between baseline, 6 months and 12 months

  • Modified North Karelia CVD risk score

    The limit values to calculate the CVD risk score were originally developed during the North Karelia project (Puska et al., 2009) and were further elaborated by Ketola (2001). The modified CVD risk score consists of six risk factors: 1. Body mass index (BMI) 2. Smoking 3. Physical inactivity 4. Systolic blood pressure 5. Diastolic blood pressure 6. Total cholesterol. The total score of the index is a sum of the 6 risk factors and the range is 0-16, the cut-off point indicating high risk of CVD is 4.5. Higher scores on the scale indicate a higher risk of cardiovascular disease. Subscore outcomes of the CVD risk score are defined as secondary outcome measures below.

    Changes between baseline, 6 months and 12 months

Secondary Outcomes (12)

  • The 6-Min Walk Test

    Changes between baseline, 6 months and 12 months

  • Blood pressure

    Changes between baseline, 6 months and 12 months

  • Waist circumference

    Changes between baseline, 6 months and 12 months

  • Body mass index

    Changes between baseline, 6 months and 12 months

  • Lipid profile

    Changes between baseline, 6 months and 12 months

  • +7 more secondary outcomes

Other Outcomes (1)

  • Family support

    Baseline, 6 months and twelve months

Study Arms (2)

Tulppa rehabilitation

EXPERIMENTAL

8-10 weekly 3-hour group sessions and two follow-up sessions (6 and 12 months).

Behavioral: Tulppa rehabilitation

Control group

NO INTERVENTION

Control group does not receive Tulppa rehabilitation during the study.

Interventions

The intervention includes health education on e.g. healthy diet, weight management, physical activity and psychosocial coping as well as peer discussions and physical exercises.

Tulppa rehabilitation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Study group: Patients diagnosed with coronary heart disease taking part in the Tulppa cardiac rehabilitation program at Pirkanmaa, South Karelia and Päijät-Häme health districts
  • Control group: Patients diagnosed with coronary heart disease, living in the area of Turku or Hyvinkää which are health districts that do not provide Tulppa rehabilitation.

You may not qualify if:

  • Acute and severe mental health problems, alcohol abuse, major limitations in physical activities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Foundation

Helsinki, Malminkartano, 00410, Finland

Location

MeSH Terms

Conditions

Coronary DiseaseCardiovascular Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesVascular Diseases

Study Officials

  • Erja Poutianen, PhD

    Rehabilitation Foundation

    STUDY DIRECTOR
  • Mila Gustavsson-Lilius, PhD

    Rehabilitation Foundation

    PRINCIPAL INVESTIGATOR
  • Piia Pietilä, MA

    Rehabilitation Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Longitudinal controlled study: The intervention group (n=150) participates in Tulppa rehabilitation program and the control group (n=150) do not participate in Tulppa rehabilitation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2018

First Posted

February 19, 2018

Study Start

February 19, 2018

Primary Completion

December 14, 2020

Study Completion (Estimated)

December 1, 2029

Last Updated

July 15, 2024

Record last verified: 2024-07

Locations